5.08.2014

No linear association between drug prices and perceived benefit criticises US cancer expert...

Dear all,

pricing of cancer drugs and now also hepatitis C has steered another debate among US payers and physicians about drug prices. See a recent article in business week.

Cheers
Ulf

No comments: